UNC Lineberger News

Doctors not adequately informing patients of cancer screening pros and cons, study finds

Though cancer screening has come a long way, physicians still do not thoroughly discuss with patients the advantages and disadvantages of these procedures before decisions are made to undergo the screenings, according to a new study co-authored by a physician from The University of North Carolina at Chapel Hill’s Gillings School of Global Public Health.

Doctors not adequately informing patients of cancer screening pros and cons, study finds - Read More…

UNC-developed tools improve accuracy of cancer DNA sequencing

The ability of researchers and physicians to use DNA sequencing to pinpoint the genetic mutations that cause cancer has led to greater understanding of the causes of the disease and development of drugs that treat tumors by targeting specific mutations. A pair of papers published by researchers at the UNC Lineberger Comprehensive Cancer Center reveal new tools that can improve the accuracy of tumor sequencing.

UNC-developed tools improve accuracy of cancer DNA sequencing - Read More…

Chen chosen for ASCO Leadership Development Program

The American Society of Clinical Oncology (ASCO) has chosen Ronald Chen, MD, MPH, assistant professor of radiation oncology and member of the UNC Lineberger Comprehensive Cancer Center, as a member of the 2014-2015 ASCO Leadership Development Program.

Chen chosen for ASCO Leadership Development Program - Read More…

WRAL story highlights bladder cancer vaccine study at UNC

A story that ran on Raleigh-based CBS affiliate WRAL focuses on a new bladder cancer vaccine being studied at UNC, called Impact Therapy. The vaccine works to target cancer cells with minimal side effects.

WRAL story highlights bladder cancer vaccine study at UNC - Read More…

Shared decision making still lacking for cancer screening

NEW YORK (Reuters Health) - When it comes to cancer screening, doctors often do not adequately discuss the balance of pros and cons with their patients, a new study suggests.

Shared decision making still lacking for cancer screening - Read More…

Indian delegation tours UNC Lineberger

A delegation from the Tata Memorial Centre cancer hospital in Mumbai, India visited the UNC Lineberger Comprehensive Cancer Center as part of a U.S. tour visiting comprehensive cancer centers. The visit, sponsored through the National Cancer Institute’s (NCI) Liaison for International Partnerships, was intended to share knowledge about how American universities and hospitals operate a comprehensive cancer center.

Indian delegation tours UNC Lineberger - Read More…

BB&T “Comfort Cart” comes with care

Close to a dozen BB&T employees recently gave their morning to volunteer at the Patient and Family Resource Center (PFRC) at the N.C. Cancer Hospital. They came to deliver the BB&T “Comfort Cart,” a rolling cart filled with snacks to comfort and sustain cancer patients and their families while they are at the cancer hospital. They brought enough granola bars, nutrition shakes and other non-perishable snacks to keep the cart stocked for months. They also brought the gifts of housekeeping and organization.

BB&T “Comfort Cart” comes with care - Read More…

UNC/Rex team up for 2014 Susan G. Komen Triangle Race for the Cure

UNC/Rex team up for 2014 Susan G. Komen Triangle Race for the Cure

The UNC/Rex team joined thousands of cancer survivors and supporters on Saturday, June 14th for the 18th annual Susan G. Komen Triangle Race for the Cure at Meredith College in Raleigh.

UNC/Rex team up for 2014 Susan G. Komen Triangle Race for the Cure - Read More…

Vanderwalde awarded Conquer Cancer Foundation Young Investigator Award

Noam Vanderwalde, MD, a radiation oncology resident at the N.C. Cancer Hospital, was awarded a 2014 Young Investigator Award by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO).

Vanderwalde awarded Conquer Cancer Foundation Young Investigator Award - Read More…

UNC researchers pinpoint new role for enzyme in DNA repair, kidney cancer

The discovery, from the lab of Brian Strahl, PhD, offers insights for the creation of better, more targeted therapies for various forms of cancer.

UNC researchers pinpoint new role for enzyme in DNA repair, kidney cancer - Read More…